Nippon India Pharma Fund - Growth Plan - Growth Option

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Nippon India Pharma Fund - Growth Plan - Growth Option
Rating
Fund
Time to Invest
Nippon India Pharma Fund - Growth Plan - Growth Option
NAV
280.0869
(18/08/2022)
L 52Wk H
253.79
317.43
Login using to know what your Friends are Investing !

Nippon India Pharma Fund - Growth Plan - Growth Option

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Nippon India Pharma Fund - Growth Plan - Growth Option
Fund
NAV
280.0869
(18/08/2022)
Time to Invest
Nippon India Pharma Fund - Growth Plan - Growth Option
Rating
L 52Wk H
253.79
317.43

Asset Allocation for Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

70.25 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(14.91%)
Cipla LimitedCipla Limited(8.46%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(7.53%)
Divi's Laboratories LimitedDivi's Laboratories Limited(7.47%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(6.48%)
Lupin LimitedLupin Limited(6.00%)
Narayana Hrudayalaya LimitedNarayana Hrudayalaya Limited(5.75%)
Abbott India LimitedAbbott India Limited(5.60%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(4.14%)
Fortis Healthcare LimitedFortis Healthcare Limited(3.92%)

Detailed Portfolio of Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Portfolio Date -31 Jul 2022
Equity Holdings -27
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 14.91% 688.628 Cr
Cipla Limited 8.46% 390.960 Cr
Dr. Reddy's Laboratories Limited 7.53% 347.680 Cr
Divi's Laboratories Limited 7.47% 345.226 Cr
Torrent Pharmaceuticals Limited 6.48% 299.176 Cr
Lupin Limited 6.00% 276.965 Cr
Narayana Hrudayalaya Limited 5.75% 265.497 Cr
Abbott India Limited 5.60% 258.837 Cr
Aurobindo Pharma Limited 4.14% 191.450 Cr
Fortis Healthcare Limited 3.92% 180.993 Cr
JB Chemicals & Pharmaceuticals Limited 3.24% 149.877 Cr
Sanofi India Limited 3.05% 140.989 Cr
Gland Pharma Limited 2.94% 135.633 Cr
Apollo Hospitals Enterprise Limited 2.74% 126.694 Cr
Thyrocare Technologies Limited 2.44% 112.855 Cr
Pfizer Limited 2.43% 112.227 Cr
Alkem Laboratories Limited 1.97% 91.082 Cr
Zydus Lifesciences Limited 1.85% 85.334 Cr
Ajanta Pharma Limited 1.64% 75.527 Cr
Indoco Remedies Limited 1.53% 70.700 Cr
Vijaya Diagnostic Centre Limited 1.42% 65.782 Cr -
IPCA Laboratories Limited 1.09% 50.101 Cr -
Rainbow Childrens Medicare Limited 0.76% 35.043 Cr -
Orchid Pharma Limited 0.70% 32.185 Cr
Tarsons Products Limited 0.60% 27.807 Cr -
Jubilant Pharmova Limited 0.43% 19.889 Cr
Healthcare Global Enterprises Limited 0.27% 12.463 Cr
Holdings % Weight Value Sahi Hai/Nahi
Triparty Repo 0.89% 41.052 Cr -
Cash Margin - CCIL 0.00% 0.023 Cr -
Net Current Assets -0.24% -11.138 Cr -

Insight on the composition of the Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option

Style Box of the Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option

Portfolio Characteristics of the Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option